These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cephalexin-induced Stevens-Johnson syndrome. Murray KM; Camp MS Ann Pharmacother; 1992 Oct; 26(10):1230-3. PubMed ID: 1421644 [TBL] [Abstract][Full Text] [Related]
5. Drug-induced Stevens-Johnson syndrome: case series from tertiary care centre in Gujarat. Bang D; Shah T; Thakker D; Shah Y; Raval AD Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):384-95. PubMed ID: 22374707 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations. Teraki Y; Shibuya M; Izaki S Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350 [TBL] [Abstract][Full Text] [Related]
7. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study. Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132 [TBL] [Abstract][Full Text] [Related]
8. Possible cefotaxime-induced Stevens-Johnson syndrome. Liberopoulos EN; Liamis GL; Elisaf MS Ann Pharmacother; 2003 Jun; 37(6):812-4. PubMed ID: 12773067 [TBL] [Abstract][Full Text] [Related]
9. Analysis of body constitution of fifty-two patients with Stevens-Johnson Syndrome (SJS) using Kampo Medical Questionnaires: prediction of SJS based on body constitution using decision tree. Ohshima S; Hatori Y; Honma S; Terasawa K; Saitoh Y; Kobayashi D Yakugaku Zasshi; 2011; 131(5):745-56. PubMed ID: 21532271 [TBL] [Abstract][Full Text] [Related]
11. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report. Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493 [TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome associated with furosemide: a case report. Wright AA; Vesta KS; Stark JE; Smith WJ J Pharm Pract; 2010 Aug; 23(4):367-70. PubMed ID: 21507837 [TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome induced by carbamazepine. Czajkowski R; Weiss-Rostkowska V; Wankiewicz A; Drewa T; Placek W; Biedka M; Zegarska B Acta Pol Pharm; 2007; 64(1):89-92. PubMed ID: 17665856 [TBL] [Abstract][Full Text] [Related]
14. Stevens - Johnson syndrome due to nevirapine. Namayanja GK; Nankya JM; Byamugisha JK; Ssali FN; Kityo CM; Rwambuya SD; Mugerwa RD; Mmiro FA; Morrison CS; Salata RA Afr Health Sci; 2005 Dec; 5(4):338-40. PubMed ID: 16615847 [TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome as an unusual adverse effect of azithromycin. Brkljacić N; Gracin S; Prkacin I; Sabljar-Matovinović M; Mrzljak A; Nemet Z Acta Dermatovenerol Croat; 2006; 14(1):40-5. PubMed ID: 16603101 [TBL] [Abstract][Full Text] [Related]
16. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report. Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616 [TBL] [Abstract][Full Text] [Related]